BioSig Technologies Inc (OTC:BSGM)‘s stock had its “buy” rating reiterated by investment analysts at Chardan Capital in a research report issued on Sunday.

Shares of BioSig Technologies (OTC:BSGM) opened at 1.41 on Friday. BioSig Technologies has a 12-month low of $1.20 and a 12-month high of $2.00. The firm’s market capitalization is $36.56 million. The stock’s 50 day moving average price is $1.35 and its 200-day moving average price is $1.44.

ILLEGAL ACTIVITY NOTICE: “BioSig Technologies’ (BSGM) “Buy” Rating Reiterated at Chardan Capital” was published by American Banking News and is the sole property of of American Banking News. If you are accessing this piece on another publication, it was stolen and republished in violation of international copyright and trademark legislation. The correct version of this piece can be accessed at

BioSig Technologies Company Profile

BioSig Technologies, Inc is a development-stage medical device company. The Company is developing a technology platform to manage noise and artifacts from cardiac recordings during electrophysiology studies and ablation. It is engaged in developing the Precise Uninterrupted Real-time evaluation of Electrograms (PURE) electro-pneumatic (EP) System.

Receive News & Ratings for BioSig Technologies Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for BioSig Technologies Inc and related companies with's FREE daily email newsletter.